Latest & greatest articles for influenza

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on influenza or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on influenza and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for influenza

221. Conjugate Haemophilus influenzae type b vaccines for sickle cell disease. Full Text available with Trip Pro

Conjugate Haemophilus influenzae type b vaccines for sickle cell disease. People affected with sickle cell disease are at high risk of infection from Haemophilus influenzae type b. Before the implementation of Haemophilus influenzae type b conjugate vaccination in high-income countries, this was responsible for a high mortality rate in children under five years of age. In African countries, where coverage of this vaccination is still extremely low, Haemophilus influenzae type b remains one (...) of the most common cause of bacteraemias in children with sickle cell disease. The increased uptake of this conjugate vaccination may substantially improve the survival of children with sickle cell disease.The primary objective was to determine whether Haemophilus influenzae type b conjugate vaccines reduce mortality and morbidity in children and adults with sickle cell disease.The secondary objectives were to assess the following in children and adults with sickle cell disease: the immunogenicity

2016 Cochrane

222. Probable Hospital Cluster of H7N9 Influenza Infection. Full Text available with Trip Pro

Probable Hospital Cluster of H7N9 Influenza Infection. 26863372 2016 02 24 2017 04 06 1533-4406 374 6 2016 02 11 The New England journal of medicine N. Engl. J. Med. Probable Hospital Cluster of H7N9 Influenza Infection. 596-8 10.1056/NEJMc1505359 Farooqui Amber A Shantou University Medical College, Shantou, China. Liu Weidong W Second Affiliated Hospital, Shantou, China. Zeng Tiansheng T Shantou University Medical College, Shantou, China. Liu Yisu Y Shantou University Medical College, Shantou (...) of Infection and Immunity, Shantou, China. dkelvin@jidc.org H7N9 Shantou Working Group eng Letter Research Support, Non-U.S. Gov't United States N Engl J Med 0255562 0028-4793 AIM IM N Engl J Med. 2016 Sep 8;375(10):e23 27602686 N Engl J Med. 2016 Sep 8;375(10):e23 27602687 Adult China Cross Infection Hospitals, University Humans Infectious Disease Transmission, Patient-to-Professional Influenza A Virus, H7N9 Subtype genetics isolation & purification Influenza, Human transmission virology Male Phylogeny

2016 NEJM

223. Characterization of evolutionary changes in hemagglutinin of influenza H1N1 virus: a computational analysis Full Text available with Trip Pro

Characterization of evolutionary changes in hemagglutinin of influenza H1N1 virus: a computational analysis Influenza virus continues to evolve due to changes in the genome and the new strain of virus is more pathogenic then the previous strain. These changes may also help the virus to cross specie barrier and may also affect the binding pattern of virus.The main theme of the current study is the identification of changes in the hemagglutinin sequence of H1N1 virus from 1960 to 2011 and also

2016 Virusdisease

224. Expert Opinion on neuraminidase inhibitors for prevention and treatment of influenza (Feb 2016)

Expert Opinion on neuraminidase inhibitors for prevention and treatment of influenza (Feb 2016) DRAFT SCIENTIFIC ADVICE FOR CONSULTATION ECDC PRELIMINARY SCIENTIFIC ADVICE Expert Opinion on neuraminidase inhibitors for prevention and treatment of influenza Review of recent systematic reviews and meta-analyses ii This report of the European Centre for Disease Prevention and Control (ECDC) was coordinated by Pasi Penttinen and Kari Johansen. Contributing authors Emmanuel Robesyn, Eeva Broberg (...) under copyright and cannot be used for purposes other than this publication without the express permission of the copyright holder. SCIENTIFIC ADVICE Expert Opinion on Neuraminidase inhibitors for prevention and treatment of influenza iii Contents Abbreviations iv Glossary v Executive summary 1 Background 3 Request for ECDC Expert Opinion 5 Methods 6 Results and discussion 8 General characteristics of the systematic reviews and meta-analyses reviewed by ECDC expert group 8 Treatment of outpatients

2016 European Centre for Disease Prevention and Control - Expert Opinion

225. Cohort study: Influenza vaccination and egg allergy: another step forward

Cohort study: Influenza vaccination and egg allergy: another step forward Influenza vaccination and egg allergy: another step forward | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password (...) * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Influenza vaccination and egg allergy: another step forward Article Text Aetiology/Harm Cohort study Influenza vaccination and egg allergy: another step forward Anne Des Roches , Louis Paradis Statistics from Altmetric.com Commentary on: Turner PJ

2016 Evidence-Based Medicine

226. The proportion of lab confirmed influenza in healthy children presenting with influenza-like illnesses

The proportion of lab confirmed influenza in healthy children presenting with influenza-like illnesses Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web

2016 PROSPERO

227. Systematic review and meta-analysis of herd protection derived from vaccinating children against seasonal influenza: implications for policy

Systematic review and meta-analysis of herd protection derived from vaccinating children against seasonal influenza: implications for policy Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2016 PROSPERO

228. Efficacy and effectiveness of influenza vaccination in healthy adults: a systematic review and meta-analysis

Efficacy and effectiveness of influenza vaccination in healthy adults: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation

2016 PROSPERO

229. Barriers and facilitators to pandemic influenza vaccination uptake in children across European countries a rapid literature review

Barriers and facilitators to pandemic influenza vaccination uptake in children across European countries a rapid literature review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2016 PROSPERO

230. WHO Global Action Plan for Influenza Vaccines report on online survey for the GAPIII consultation

WHO Global Action Plan for Influenza Vaccines report on online survey for the GAPIII consultation WHO Global Action Plan for Influenza Vaccines report on online survey for the GAPIII consultation JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links WHO Global Action Plan for Influenza Vaccines report on online survey for the GAPIII consultation View/ Open View Statistics Altmetrics (...) Share Citation World Health Organization . (‎2016)‎. WHO Global Action Plan for Influenza Vaccines report on online survey for the GAPIII consultation. World Health Organization. Description 39 p. Gov't Doc # WHO/HIS/TTi/GAP/16.1 Collections Language English Metadata Related items Showing items related by title and MeSH subject.  World Health Organization (‎ 1998 )‎  World Health Assembly, 63 (‎ A63/48 , 2010 )‎  World Health Assembly, 64 (‎ A64/8A64/8 Corr.1 , 2011 )‎ View Item

2016 WHO

231. Barriers of influenza vaccination intention and behavior: a systematic review of influenza vaccine hesitancy 2005 – 2016

Barriers of influenza vaccination intention and behavior: a systematic review of influenza vaccine hesitancy 2005 – 2016 Barriers of influenza vaccination intention and behavior: a systematic review of influenza vaccine hesitancy 2005 – 2016 JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Barriers of influenza vaccination intention and behavior: a systematic review (...) of influenza vaccine hesitancy 2005 – 2016 View/ Open View Statistics Altmetrics Share Citation World Health Organization . (‎2016)‎. Barriers of influenza vaccination intention and behavior: a systematic review of influenza vaccine hesitancy 2005 – 2016. World Health Organization. Description 72 p. Gov't Doc # WHO/HIS/TTi/GAP/16.2 Collections Language English Metadata Related items Showing items related by title and MeSH subject.  World Health Assembly, 71 (‎ A71/24 , 2018 )‎  World Health Organization

2016 WHO

232. Systematic review and meta-analysis of indirect effectiveness of influenza vaccination on disease incidence in non-target populations and relation to vaccination coverage

Systematic review and meta-analysis of indirect effectiveness of influenza vaccination on disease incidence in non-target populations and relation to vaccination coverage Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation

2016 PROSPERO

233. Risk factors for seasonal influenza disease with severe outcomes

Risk factors for seasonal influenza disease with severe outcomes Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures

2016 PROSPERO

234. Assessing the state of knowledge regarding the effectiveness of interventions to contain pandemic influenza transmission: a systematic review of systematic reviews and meta-analyses

Assessing the state of knowledge regarding the effectiveness of interventions to contain pandemic influenza transmission: a systematic review of systematic reviews and meta-analyses Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2016 PROSPERO

235. Assessing the effectiveness of personal protective measures in reducing pandemic influenza transmission: a systematic review

Assessing the effectiveness of personal protective measures in reducing pandemic influenza transmission: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2016 PROSPERO

236. Compare the human transmissibility between influenza A/H7N9 and A/H5N1: a systematic review of reproduction numbers

Compare the human transmissibility between influenza A/H7N9 and A/H5N1: a systematic review of reproduction numbers Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2016 PROSPERO

237. Tool for Influenza Pandemic Risk Assessment (TIPRA)

Tool for Influenza Pandemic Risk Assessment (TIPRA) Tool for Influenza Pandemic Risk Assessment (‎TIPRA)‎ JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Tool for Influenza Pandemic Risk Assessment (‎TIPRA)‎ View/ Open View Statistics Altmetrics Share Citation World Health Organization . (‎2016)‎. Tool for Influenza Pandemic Risk Assessment (‎TIPRA)‎. World Health Organization

2016 WHO

238. The impact of repeat vaccination on influenza vaccine effectiveness: a systematic review

The impact of repeat vaccination on influenza vaccine effectiveness: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing

2016 PROSPERO

239. Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits Report by the Director-GeneralPandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits: report by the Di

Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits Report by the Director-GeneralPandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits: report by the Di Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits: report by the Director-General JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle (...) navigation Toggle navigation Search Browse Statistics Related Links Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits: report by the Director-General View/ Open View Statistics Altmetrics Share Citation World Health Assembly, 69 . (‎2016)‎. Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits: report by the Director-General. World Health Organization. Gov't Doc # A69/22 Collections Language English

2016 WHO

240. Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits: report of the Special Session of the Pandemic Influenza Preparedness Framework Advisory Group

Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits: report of the Special Session of the Pandemic Influenza Preparedness Framework Advisory Group Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits: report of the Special Session of the Pandemic Influenza Preparedness Framework Advisory Group JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle (...) navigation Toggle navigation Search Browse Statistics Related Links Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits: report of the Special Session of the Pandemic Influenza Preparedness Framework Advisory Group View/ Open View Statistics Altmetrics Share Citation World Health Assembly, 69 . (‎2016)‎. Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits: report of the Special Session of the Pandemic

2016 WHO